Crinetics was founded by a team of scientists with a track record of drug discovery and development. We are dedicated to creating important new therapeutic options for patients with endocrine diseases and endocrine-related tumors.

Meet Us


scott struthers uai

R. Scott Struthers, Ph.D.

Founder & Chief Executive Officer

garlan adams web uai

Garlan Adams

General Counsel

stephen f. betz, ph.d. founder & chief scientific officer executive team

Stephen F. Betz, Ph.D.

Founder & Chief Scientific Officer

cabre uai

Adriana Cabré, MBA

Chief Human Resources Officer

jim hassard uai

Jim Hassard

Chief Commercial Officer

jacqueline kirby, vice president of corporate affairs

Jacqueline Kirby

Senior Vice President, Corporate Affairs

jeff knight chief operating office executive team

Jeff Knight

Chief Operating Officer

alan krasner uai

Alan S. Krasner, M.D.

Chief Endocrinologist

dana p uai

Dana Pizzuti, M.D.

Chief Medical and Development Officer

chris robillard uai

Chris Robillard, MBA

Chief Business Officer

marc-wilson-cfo-crinetics-pharmaceuticals

Marc Wilson

Chief Financial Officer

Caren Deardorf

Board Member

Matthew K. Fust

Board Member

Weston Nichols, Ph.D.

Board Member

R. Scott Struthers, Ph.D.

Founder & Chief Executive Officer

John Newell-Price, M.D., Ph.D.

Scientific Advisory Board

Martin Heinrich Reincke, M.D.

Scientific Advisory Board

William Young, M.D.

Scientific Advisory Board

Beverly MK Biller, M.D., FACP

Scientific Advisory Board

Ann Taylor, M.D.

Scientific Advisory Board

Joy Wu, M.D., Ph.D., FASBMR

Scientific Advisory Board